{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-035618","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2024-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.151259+00:00","generated_at":"2026-05-31T13:04:14.523591+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"PDS Biotech VERSATILE-002 abstract accepted for ESMO 2024 presentation","bullets":["Abstract on first-line Versamune HPV + KEYTRUDA in HPV16-positive recurrent/metastatic HNSCC accepted for ESMO.","Poster number 879P; session at ESMO Congress 2024 in Barcelona, Sept 13-17.","Presenting author: Dr. Jared Weiss, Section Chief at UNC and trial PI.","Poster title includes survival data; no clinical results disclosed in this release."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-035618","json":"https://secwatch.observer/filing/0001140361-24-035618.json","markdown":"https://secwatch.observer/filing/0001140361-24-035618.md","text":"https://secwatch.observer/filing/0001140361-24-035618.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036124035618/0001140361-24-035618-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036124035618/ef20033543_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:04:14.523591+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}